EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serological insights from SARS-CoV-2 heterologous prime and boost responses in Thailand

Daniel Ward, Lapasrada Pattarapreeyakul, Rujiraporn Pitaksalee, Naphatcha Thawong, Waritta Sawaengdee, Suthida Tuntigumthon, Catriona Patterson, Kevin Tetteh, Susana Campino, Panadda Dhepakson, Surakameth Mahasirimongkol, Taane G Clark

Scientific Reports · 09.01.2025 · 15 (1)

DOI: 10.1038/s41598-024-84392-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Scientific Reports, online erschienen am 09.01.2025. Verfasst von Daniel Ward und 11 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine (LSHTM), Keppel Street, London, WC1E 7HT, UK. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19, Antibodies, Viral. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

During the COVID-19 pandemic, heterologous vaccination strategies were employed to alleviate the strain on vaccine supplies. The Thailand Ministry of Health adopted these strategies using vector, inactivated, and mRNA vaccines. However, this approach has introduced challenges for SARS-CoV-2 sero-epidemiology studies. Our study analysed 647 samples from healthcare workers who received CoronaVac, ChAdOx1 nCoV-19, and BNT162b2 vaccines. The serological profile encompassed responses to various SARS-CoV-2 variants and vectors, measuring IgG, IgM, and IgA isotypes, alongside IgG avidity assays. The results demonstrated that heterologous CoronaVac/ChAdOx1 nCoV-19 schedules elicited significantly stronger antibody responses compared to homologous schedules (IgG: 1.2-fold, IgM: 10.9-fold, IgA: 3.1-fold increase). Additionally, a heterologous BNT162b2 boost at 4-weeks post-initial vaccination showed greater antibody levels than a ChAdOx1 nCoV-19 boost (IgG: 1.1-fold, IgM: slight decrease, IgA: 1.5-fold increase). Using a combination of three analytes, IgG against wild-type Spike trimer, nucleoprotein and Omicron receptor binding domains, enabled the clustering of responses within a statistical Gaussian mixture model that successfully discriminates between breakthrough infections and vaccination types (F-score = 0.82). The development of statistical models to predict breakthrough infections can improve serological surveillance. Overall, our study underscores the necessity for vaccine (re-)development and the creation of serological tools to monitor vaccine performance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19Antibodies, ViralHumansThailandCOVID-19 VaccinesImmunoglobulin GMaleFemaleBNT162 VaccineImmunization, SecondaryImmunoglobulin MChAdOx1 nCoV-19AdultImmunoglobulin AMiddle AgedVaccinationHealth PersonnelSpike Glycoprotein, Coronavirus

Stichwörter der Autor:innen

AntibodyCOVID-19SARS-CoV-2Vaccine

Substanzen

Antibodies, ViralCOVID-19 VaccinesImmunoglobulin GBNT162 VaccineImmunoglobulin MChAdOx1 nCoV-19Immunoglobulin ASpike Glycoprotein, Coronavirus

Autor:innen und Institutionen

  • Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine (LSHTM), Keppel Street, London, WC1E 7HT, UK.
  • Department of Medical Sciences, Medical Life Sciences Institute, Ministry of Public Health, 88/7 Tiwanon Road, Nonthaburi, 11000, Thailand.
  • Department of Medical Sciences, Medical Life Sciences Institute, Ministry of Public Health, 88/7 Tiwanon Road, Nonthaburi, 11000, Thailand. surakameth.m@dmsc.mail.go.th.
  • Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine (LSHTM), Keppel Street, London, WC1E 7HT, UK. taane.clark@lshtm.ac.uk.
  • Faculty of Epidemiology and Population Health, LSHTM, London, UK. taane.clark@lshtm.ac.uk.

Zitieren

APA

Ward, D., Pattarapreeyakul, L., Pitaksalee, R., Thawong, N., Sawaengdee, W., Tuntigumthon, S., Patterson, C., Tetteh, K., Campino, S., Dhepakson, P., Mahasirimongkol, S., & Clark, T. G. (2025). Serological insights from SARS-CoV-2 heterologous prime and boost responses in Thailand. Scientific Reports, 15(1). https://doi.org/10.1038/s41598-024-84392-2

Vancouver

Ward D, Pattarapreeyakul L, Pitaksalee R, Thawong N, Sawaengdee W, Tuntigumthon S, et al. Serological insights from SARS-CoV-2 heterologous prime and boost responses in Thailand. Scientific Reports. 2025;15(1). doi:10.1038/s41598-024-84392-2

BibTeX
@article{Ward2025,
  author = {Ward, Daniel and Pattarapreeyakul, Lapasrada and Pitaksalee, Rujiraporn and Thawong, Naphatcha and Sawaengdee, Waritta and Tuntigumthon, Suthida and Patterson, Catriona and Tetteh, Kevin and Campino, Susana and Dhepakson, Panadda and Mahasirimongkol, Surakameth and Clark, Taane G},
  title = {Serological insights from SARS-CoV-2 heterologous prime and boost responses in Thailand},
  journal = {Scientific Reports},
  year = {2025},
  volume = {15},
  number = {1},
  doi = {10.1038/s41598-024-84392-2}
}
Kostenlos starten →